BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15917698)

  • 21. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
    Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
    J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin melanoma of the head and neck. Prognostic factors and recurrence-free survival in 512 patients.
    Andersson AP; Gottlieb J; Drzewiecki KT; Hou-Jensen K; Sondergaard K
    Cancer; 1992 Mar; 69(5):1153-6. PubMed ID: 1739914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of tumour thickness in cutaneous malignant melanoma.
    Jeffrey I; Royston P; Sowter C; Slavin G; Price A; Pomerance A; Goolamali S; Pinto D
    J Clin Pathol; 1983 Jan; 36(1):51-6. PubMed ID: 6822677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of melanoma features and their relationship with nodal disease: the importance of the pathological report.
    Bertolli E; de Macedo MP; Pinto CA; Damascena AS; Molina AS; Ueno PS; Duprat Neto JP
    Tumori; 2015; 101(5):501-5. PubMed ID: 25983100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitotic rate as an important prognostic factor in cutaneous malignant melanoma.
    Piñero-Madrona A; Ruiz-Merino G; Cerezuela Fuentes P; Martínez-Barba E; Rodríguez-López JN; Cabezas-Herrera J
    Clin Transl Oncol; 2019 Oct; 21(10):1348-1356. PubMed ID: 30783917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
    Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
    Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in melanoma survival are not related to mitotic rate of the primary tumor.
    Joosse A; van der Ploeg AP; Haydu LE; Nijsten TE; de Vries E; Scolyer RA; Eggermont AM; Coebergh JW; Thompson JF
    Ann Surg Oncol; 2015 May; 22(5):1598-603. PubMed ID: 25408275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcoma-like tumor of head and neck skin.
    Nonaka D; Bishop PW
    Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A critical review of melanoma pathology reports for patients referred to the Western Australian Melanoma Advisory Service.
    Monshizadeh L; Hanikeri M; Beer TW; Heenan PJ
    Pathology; 2012 Aug; 44(5):441-7. PubMed ID: 22772338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.
    Rees MJ; Liao H; Spillane J; Speakman D; McCormack C; Donahoe S; Pohl M; Webb A; Gyorki D; Henderson MA
    Eur J Surg Oncol; 2016 Sep; 42(9):1359-66. PubMed ID: 26899940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in head and neck mucosal malignant melanoma.
    Çomoğlu Ş; Polat B; Çelik M; Şahin B; Enver N; Keleş MN; Sarı ŞÖ
    Auris Nasus Larynx; 2018 Feb; 45(1):135-142. PubMed ID: 28385366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors for metastasis in cutaneous melanoma.
    Cherobin ACFP; Wainstein AJA; Colosimo EA; Goulart EMA; Bittencourt FV
    An Bras Dermatol; 2018; 93(1):19-26. PubMed ID: 29641692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is head and neck melanoma different from trunk and extremity melanomas with respect to sentinel lymph node status and clinical outcome?
    Fadaki N; Li R; Parrett B; Sanders G; Thummala S; Martineau L; Cardona-Huerta S; Miranda S; Cheng ST; Miller JR; Singer M; Cleaver JE; Kashani-Sabet M; Leong SP
    Ann Surg Oncol; 2013 Sep; 20(9):3089-97. PubMed ID: 23649930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.